- AdventHealth
AdventHealth gynecologic surgeon Steven D. McCarus, MD, FACOG, published an article in Surgery Technology International that reviewed the evolution of the HARMONIC® scalpel, a surgical instrument first released in 1988 that uses ultrasonic vibrations to simultaneously cut and cauterize tissue.
The use of ultrasonic energy in surgery originated from surgeons’ desires to continually improve outcomes through more effective methods and instrumentation. Instead of using electricity to achieve hemostasis, ultrasonic energy uses the mechanical energies of coaptation and cavitation to achieve precise tissue cutting and sealing. Gynecological surgeons were among the first to use this technology for a number of procedures, including coagulating or excising endometriosis, removal of uterine fibroids, tubal surgery, ovarian surgery, colpotomy, and total and subtotal hysterectomies. However, surgeons from a variety of specialties now use it, including general surgery, breast, colorectal, thoracic and bariatric.
Over the years, the HARMONIC® scalpel technology has continued to evolve, providing surgeons with increased precision and versatility, and allowing for use in minimally invasive procedures that are performed with smaller incisions. Surgeons have reported that using HARMONIC® devices resulted in shorter surgical times because tissue is quickly cut, coagulated and sealed with one instrument. Hospitals have also noted reductions in total reported costs and operation-only costs.
Numerous clinical trials and meta-analysis studies over the years have compared the use of ultrasonic energy to conventional methods for a variety of surgical procedures. Documented clinical benefits for patients have included less collateral tissue damage, fewer complications, a reduction in postoperative pain and/or postoperative medications, less drainage and postoperative bleeding, reduced length of stay and quicker return to work.
In his article, Dr. McCarus reports that the ability of ultrasonic energy to be used near vital organs with precision by adjusting for tissue tension, power settings and activation time has accounted for its safety and clinical outcomes. He concludes that as the HARMONIC technology and ultrasonic energy platforms continue to advance, the focus should remain on achieving less tissue trauma and faster recovery.
View the full document here.
Recent News
Physician leaders from AdventHealth’s emergency department, infectious disease, inpatient, pediatrics and pharmacy teams all collaborated to develop a respiratory virus testing algorithm to assist...
Thoracic surgeon Colleen Gaughan, MD, and her team at AdventHealth Celebration, recently became one of the first in the country to incorporate targeted imaging agent Cytalux (pafolacianine) as part of...
On the newest Inspiring Wholeness podcast, Obie Diaz, local morning radio show host, shares how a routine physical eventually led to two open heart surgeries.
AdventHealth recently began piloting a new Genomics Risk Assessment for Cancer and Early Detection (GRACE) program that combines the use of digital mammography, artificial intelligence (AI) technology...
AdventHealth Clinical Research Unit (CRU) Executive Director and Medical Director of Genitourinary Oncology Guru Sonpavde, MD, co-authored an article on the AMBASSADOR Phase III clinical trial results...
AdventHealth is accelerating the use of research-backed best practices for treating pediatric respiratory infections to combat antibiotic resistance and improve patient outcomes.
A promising new treatment for AFib patients called Pulse Field Ablation is first offered in Central Florida at AdventHealth and shows less damage to tissue.
Plastic and Reconstructive Microsurgeon Sabrina Pavri, MD, and Breast Surgeon Devina McCray, MD, recently began offering immediate neurotization after breast reconstruction, a new surgical technique...
Explore the importance of Hispanic representation in our community in this episode of the Inspiring Wholeness podcast.
Under the leadership of gynecologist and gynecological surgeon Omar Zwain, MD, AdventHealth for Women opened its new, multidisciplinary Comprehensive Fibroid Program at AdventHealth Winter Park in...
Under the leadership of Medical Director of Genomics and Personalized Health Majed Dasouki, MD, AdventHealth for Children is recruiting patients for a new Phase III clinical trial to evaluate the...
Hepato-pancreato-biliary (HPB) surgeon Andrew Guzowski, MD, performed AdventHealth’s first liver histotripsy, a non-invasive treatment for certain patients with unresectable liver tumors.